GRCE vs KLAC · $35.0M cap vs P/E 55, rev $12.16B
Grace Therapeutics, Inc. (GRCE) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
GRCE does not have a complete income-statement cache yet.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
GRCE currently screens at market cap $35.0M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the GRCE and KLAC stock pages for the full models.
Not investment advice.